Inventor · disambiguated record
Michael T. Rudd
Also filed as: RUDD MICHAEL T
32 granted patents·7 pending applications·213 citations·filing 2006–2023
96Inventor score
Files withMERCK SHARP & DOHME18MERCK SHARP & DOHME LLC8LIVERTON NIGEL J4HOLLOWAY M KATHARINE2MCCAULEY JOHN A2
Top patents by PatentIndex Score
39 records- 0197US7470664B2HCV NS3 protease inhibitorsMERCK & CO INC·Filed 2006·Granted Dec 30, 2008·81 cites·40 claims
- 0293US10512638B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2016·Granted Dec 24, 2019·8 cites·6 claims
- 0391US8216999B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2008·Granted Jul 10, 2012·26 cites·18 claims
- 0491US7879797B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Feb 1, 2011·15 cites·16 claims
- 0589US8278322B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2006·Granted Oct 2, 2012·10 cites·40 claims
- 0687US8461107B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2009·Granted Jun 11, 2013·12 cites·26 claims
- 0786US8377874B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·9 cites·13 claims
- 0885US8828930B2Hepatitis C virus NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2010·Granted Sep 9, 2014·8 cites·6 claims
- 0985US8309540B2HCV NS3 protease inhibitorsLIVERTON NIGEL J·Filed 2007·Granted Nov 13, 2012·9 cites·24 claims
- 1084US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 1182US8927569B2Macrocyclic compounds as antiviral agentsHARPER STEVEN·Filed 2008·Granted Jan 6, 2015·8 cites·17 claims
- 1281US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 1381US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 1480US12331018B2Pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·1 cites·6 claims
- 1578US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 1678US11098029B25-alkyl pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME·Filed 2020·Granted Aug 24, 2021·1 cites·12 claims
- 1777US10239849B2Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted Mar 26, 2019·2 cites·13 claims
- 1876US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 1976US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 2074US10981902B25-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted Apr 20, 2021·1 cites·18 claims
- 2164US2025282760A1Orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2260US9102673B2Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitorsHANNEY BARBARA·Filed 2012·Granted Aug 11, 2015·1 cites·14 claims
- 2355US12497362B2Cyclopentapyrrole orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 16, 2025·0 cites·13 claims
- 2455US9738661B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Aug 22, 2017·0 cites·7 claims
- 2555US2010099695A1HCV NS3 Protease InhibitorsLIVERTON NIGEL J·Filed 2007·Application pending·0 cites
- 2654US2024002397A13-amino pyrrolidine and piperidine macrocyclic orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2753US11826375B2Phosphinic amide prodrugs of tenofovirMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 28, 2023·0 cites·18 claims
- 2853US11680060B2Bicycloheptane pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Jun 20, 2023·0 cites·37 claims
- 2952US2023391795A1Macrocyclic urea orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3049US12312332B2Heteroaryl pyrrolidine and piperidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 27, 2025·0 cites·11 claims
- 3149US2024101555A1Urea orexin receptor agonistsARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 3247US8591878B2Therapeutic compoundsMCCAULEY JOHN A·Filed 2009·Granted Nov 26, 2013·0 cites·26 claims
- 3344US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 3442US11655216B2Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted May 23, 2023·0 cites·8 claims
- 3540US10961215B2N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
- 3639US10894775B2Piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 3738US10752587B2Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their useMERCK SHARP & DOHME·Filed 2016·Granted Aug 25, 2020·0 cites·10 claims
- 3838US2018305332A1Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their UseMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 3936US2013178413A1Hcv ns3 protease inhibitorsMCCAULEY JOHN A·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael T. Rudd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →